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Abstract 
Background: Non-pharmalogical interventions represent an important complement to standard pharmalogical treatment in dementia. Objective: This 
study aims to evaluate the effects of a multidisciplinary rehabilitation program on cognitive ability, quality of life and depression symptoms in patients with 
Alzheimer’s disease (AD) and cognitive impairment without dementia (CIND). Methods: Ninety-seven older adults were recruited to the present study. Of 
these, 70 patients had mild AD and were allocated into experimental (n = 54) or control (n = 16) groups. Two additional active comparison groups were 
constituted with patients with moderate AD (n = 13) or with CIND (n = 14) who also received the intervention. The multidisciplinary rehabilitation program 
lasted for 12 weeks and was composed by sessions of memory training, recreational activities, verbal expression and writing, physical therapy and physical 
training, delivered in two weekly 6-hour sessions. Results: As compared to controls, mild AD patients who received the intervention had improvements in 
cognition (p = 0.021) and quality of life (p = 0.003), along with a reduction in depressive symptoms (p < 0.001). As compared to baseline, CIND patients 
displayed at the end of the intervention improvements in cognition (p = 0.005) and depressive symptoms (p = 0.011). No such benefits were found among 
patients with moderate AD. Discussion: This multidisciplinary rehabilitation program was beneficial for patients with mild AD and CIND. However, patients 
with moderate dementia did not benefit from the intervention.
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Introduction
Non-pharmacological interventions represent an important comple-
ment to standard pharmacological treatment in dementia. Cogni-
tive, physical and psychosocial rehabilitation may improve global 
function, mental state and quality of life1-3. These interventions may 
further reduce social costs4. Different approaches have been proposed 
such as cognitive rehabilitation, occupational therapy, physical activ-
ity, music therapy, art therapy and others interventions5,6.
These non-pharmacological interventions may be delivered 
separately or in the format of combined, multimodal interventions7. 
Given the complexity of dementia and the multiple needs displayed 
by patients and caregivers along the distinct phases of the dementing 
process, interest in multimodal interventions has increased in the 
past few years8. Several studies have been performed addressing the 
treatment and prevention of cognitive impairment9-13, in samples of 
older adults with cognitive impairment without dementia (CIND), 
mild cognitive impairment5,14,15 and dementia5,7,15-17.
Multimodal intervention for patients with Alzheimer’s disease 
(AD) may help in maintaining cognitive function, community in-
dependence, reduction of depression symptoms and improving the 
quality of life of caregivers5,7. In view of the multifactorial causes of 
AD, multimodal interventions have additive or interactive effects 
and may prove more effective than single domain interventions8,18,19. 
The aim of this study was to evaluate the effect of a multidisciplinary 
rehabilitation program on cognitive ability, depression symptoms 
and quality of life in patients with mild to moderate AD and CIND.
Methods
Study design
The present study was a single-blinded intervention trial conducted 
at a university-based psychogeriatric clinic (Institute of Psychiatry, 
University of Sao Paulo, Brazil) to test the efficacy of a clinically 
oriented multimodal rehabilitation program on global function, 
cognition and quality of live of elderly patients with cognitive impair-
ment and dementia. Participants were consecutively referred to the 
rehabilitation unit from the hospital’s outpatient clinic, expecting to 
receive complementary, non-pharmacological treatment for memory 
and cognitive disorders. All participants signed informed consent 
and the study was approved by the local Ethical Committee. 
Participants
The total sample consisted of 97 older adults with various degrees 
of cognitive complaints, ranging from cognitive impairment with-
out dementia (CIND) to mild and moderate dementia due to AD. 
Participants were assessed upon enrollment by a multidisciplinary 
team composed by psychiatrists, neurologists, geriatricians, neuro-
psychologists and occupational therapists. Diagnoses were reached at 
consensus sessions taking into account all available clinical (medical, 
neuropsychological and functional) and laboratorial information, in-
cluding neuroimaging. The diagnosis of probable AD was established 
according to the NINCDS-ADRDA criteria20. The diagnosis of CIND 
was established to non-demented elders with neuropsychological 
evidence of subtle cognitive deficits affecting at least one cognitive 
domain, in the absence of medical or psychiatric abnormalities and 
other likely causes of cognitive impairment21,22. 
AD patients were included in the study if they had 60 years of 
age or more and were receiving standard pharmacological treatment 
with anti-dementia drugs, i.e., stable therapeutic daily doses of cho-
linesterase inhibitors and/or memantine for at least three months. 
Mild AD patients were expected to have scores of 17 or more in 
the Mini-Mental State Examination (MMSE)23,24 and of 0.5 or 1.0 
in the Clinical Dementia Rating Scale (CDR)25,26; for patients with 
moderate AD, MMSE and CDR scores were expectedly >13 and 2.0 
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respectively. CIND patients had CDR scores of 0.5 and MMSE scores 
above the education-corrected cut-off values that separates cases from 
controls in the Brazilian population23.
The majority of the sample comprised patients with mild AD 
(n = 70), and therefore only participants in this diagnostic group 
were evaluated in a randomized-coltrolled trial (RCT) format with 
an experimental group compared to a control group. Due to ethical 
reasons (i.e., need for treatment) the allocation into intervention 
or control groups was done at a 3:1 ratio, yielding a total of 54 
and 16 patients with mild AD respectively in the experimental 
(intervention) and control (waiting list) groups. The remaining 27 
patients of the total sample were diagnosed with moderate AD (n = 
13) or with CIND (n = 14). Because these sub-samples of patients 
were too small to warrant randomization into experimental and 
control groups, and too different clinically to merge with the for-
mer group of mild AD patients, we decided to provide treatment 
to all of them and regard these sub-samples as active comparison 
groups, addressing endpoint vs. baseline differences in outcome 
variables separately.
Outcome variables 
All participants were evaluated at baseline and endpoint by a 
rater who was blind to group assignment. The assessment bat-
tery included: MMSE23,24; Geriatric Depression Scale (GDS)27,28 
and Quality of Life scale for patients with Alzheimer’s Disease 
(QoL-AD)29 which the patient evaluates his/her own quality of 
life (PQoL-AD) and the caregiver/family assesses on the patient’s 
quality of life (CQoL-AD). 
Intervention
The intervention was delivered at the day-hospital facilities in the 
format of group sessions (10 participants per group) offered twice a 
week for 12 consecutive weeks. Sessions lasted from 9:00 am to 3:30 
pm (lunch and refreshments were provided and lasted 90 minutes), 
and the 24 sessions resulted in a total of 120 h of intervention (5 h 
daily). The program consisted of the following activities for patients: 
cognitive rehabilitation, computer assisted cognitive training, speech 
therapy, occupational therapy, art therapy, physical training, physical 
therapy, and cognitive stimulation with reading and logic games. Each 
one of these activities lasted for 60-90 minutes and was offered once 
a week. Psycho-educational workshops and psychological support 
group sessions were offered to caregivers twice a week from 10:00 am 
to 11:30 am. Detailed information about each activity can be found 
in a previous publication from our group17.
From the total 54 patients with mild AD allocated to the inter-
vention group, 8 failed to reach the experimental endpoint: three 
did not comply to all outcome assessment proceedings, two had dif-
ficulties arranging participation, one withdrew consent and therefore 
discontinued intervention, one was diagnosed with a new ill-health 
condition and one died.
Statistical analysis
Statistical procedures were undertaken with the Statistical Pack-
age for the Social Sciences (SPSS), 20.0 version for Windows, and 
significance level was defined at 5% (p = 0.05). All variables were 
initially submitted to descriptive analyzes. Categorical variables were 
shown with numbers and percentages. The Kolmogorov-Smirnov 
test was used to determine whether study variables followed a 
normal distribution, which supported the use of parametric tests. 
Independent-sample t tests were used to compare mean scores at 
baseline. Paired-sample t tests were used to compare differences 
(baseline vs. endpoint) in test scores between experimental group 
and control group. The Chi-square tests were used to compare the 
categorical variables.
Results
Sixty-two patients with mild AD completed the trial, being 46 in 
the experimental group and 16 in the control group. The socio-
demographic and clinical characteristics of the participants in these 
two groups are summarized in table 1. There were no significant 
differences in age, education level, gender, CDR scores and mean 
psychometric test scores at baseline between mild AD patients in 
experimental and control groups.
Table 1. Baseline characteristics of experimental and control patients 
with mild AD 
Characteristics Experimental 
(n = 46)
Control 
(n = 16)
p-value
Gender 
Male
Female
19 (41.3%)
27 (58.7%)
6 (37.5%)
10 (62.5%)
0.984*
Age (years) 75.7 (±5.6) 74.8 (±4.7) 0.418**
Education (years) 9.4 (±4.8) 11.0 (±5.1) 0.325**
CDR 0.5 = 8 (17.4%)
1.0 = 38 (82.6%)
0.5 = 7 (43.7%)
1.0 = 9 (56.3%)
0.089*
MMSE 23.0 (±2.5) 23.3 (±3.9) 0.958**
GDS 5.1 (±3.3) 4.3 (±3.2) 0.566**
PQoL-AD 34.9 (±6.3) 36.1 (±5.8) 0.900**
CQoL-AD 31.5 (±5.4) 31.1 (±7.4) 0.995**
AD: Alzheimer’s disease; CDR: Clinical Dementia Rating Scale; MMSE: Mini-Mental State 
Examination; GDS: Geriatric Depression Scale; PQoL-AD: Patient’s Quality of Life; CQoL-AD: 
Caregiver’s Quality of Life. Values given are mean ± standard deviation or % percentage; * Chi-
square test; ** Independent-sample t tests.
Table 2 shows the mean values and standard deviations for 
psychometric test scores at baseline and at the end of the study for 
patients with mild AD. The results indicate significant increase in 
MMSE scores (p = 0.021), a significant reduction in GDS scores (p 
< 0.001) and improvement in patients’ quality of life (p = 0.003) ac-
cording to the QoL-AD in the experimental group. No statistically 
significant differences in caregiver’s quality of life were observed be-
tween groups. No differences were observed in endpoint vs. baseline 
psychometric test scores in the control group.
Table 2. Psychometric test scores at baseline and after intervention (end-
point) mild AD groups
Variable Group Baseline Endpoint p-value*
MMSE EG 23.0 (±2.5) 23.6 (±2.9) 0.021
CG 23.3 (±3.9) 22.4 (±2.8) 0.150
GDS EG 5.1 (±3.3) 3.7 (±3.0) < 0.001
CG 4.3 (±3.2) 4.7 (±3.4) 0.561
PQoL-AD EG 34.9 (±6.3) 36.5 (±5.2) 0.003
CG 36.1 (±5.8) 35.4 (±6.1) 0.523
CQoL-AD EG 31.5 (±5.4) 32.5 (±5.7) 0.262
CG 31.1 (±7.4) 32.7 (±6.6) 0.330
EG: experimental group; CG: control group; MMSE: Mini-Mental State Examination; GDS: Geriatric 
Depression Scale; PQoL-AD: Patient’s Quality of Life; CQoL-AD: Caregiver’s Quality of Life. Values 
given are mean ± standard deviation. (*) Paired Sample t-test (baseline vs endpoint).
In the CIND group (n = 14) and moderate AD group (n = 13), 
the mean age of the patients were 72.2 and 77 years, and the patients 
had 10.6 years and 8.1 of schooling, respectively. In both groups there 
were more females (CIND group, 71.4%; moderate AD group, 77%). 
All patients in the CIND group had CDR = 0.5 and all patients in 
the moderate AD group had CDR = 2.0.
155Santos GD et al. / Arch Clin Psychiatry. 2015;42(6):153-6
There were small but statistically significant differences in the 
MMSE scores (p = 0.005) and GDS scores (p = 0.011) before and 
after intervention in CIND group, indicative of improvement. No 
statistically significant differences in psychometric test scores were 
apparent among patients with moderate AD (Table 3).
Table 3. Psychometric test scores at baseline and after intervention (end-
point) CIND and moderate AD group
Variable Group Baseline Endpoint p-value*
MMSE CIND 27.6 (±1.7) 28.4 (±1.5) 0.005
Moderate AD 15.7 (±1.2) 16.0 (±2.8) 0.613
GDS CIND 7.7 (±5.0) 6.5 (±4.7) 0.011
Moderate AD 4.4 (±2.6) 3.6 (±3.3) 0.249
PQoL-AD CIND 30.3 (±7.3) 31.9 (±9.0) 0.181
Moderate AD 34.7 (±6.0) 36.1 (±5.7) 0.370
CQoL-AD CIND 30.4 (±5.4) 33.0 (±6.2) 0.137
Moderate AD 31.6 (±7.4) 31.2 (±6.9) 0.849
CIND: Cognitive Impairment Without Dementia; AD: Alzheimer’s disease; MMSE: Mini-Mental 
State Examination; GDS: Geriatric Depression Scale; PQoL-AD: Patient’s Quality of Life; 
CQoL-AD: Caregiver’s Quality of Life. Values given are mean ± standard deviation. (*) Paired 
Sample t-test (baseline vs endpoint).
Discussion
The present study showed that patients with mild AD who received 
a multimodal experimental rehabilitation intervention (experimen-
tal group) had an improvement in global cognitive function and 
in quality of life, and a reduction in the magnitude of depressive 
symptoms compared to those in the control group. In the sub-set of 
patients with CIND, comparing the scores on these tests before and 
after the intervention, without a proper control group, we observed 
improvements in the MMSE and GDS scores. No such effects were 
found among patients with moderate AD.
Our results are in agreement with the findings of previous studies, 
which have suggested benefits in nonpharmacological intervention 
in patients with cognitive impairment and mild dementia14,30-32. 
One study that evaluated the efficacy of two different treatments to 
stimulate cognitive functions in patients with mild cognitive impair-
ment and mild dementia comparing baseline and after treatment 
performance with control group, showed a significant improvement 
in global cognitive status (MMSE) in patients with mild dementia 
and a significant reduction of depression symptoms (GDS) in both 
experimental groups33. 
Although, in this study no significant statistical difference was 
observed in moderate AD group, some studies showed benefits for 
these patients3,32,34. Other study that evaluated the effect of remi-
niscence therapy on the cognitive status and depression in patients 
with mild and moderate AD showed statistically significant the 
increase in mean MMSE scores and the decrease in GDS scores in 
the intervention group than control group1. In a recent study of the 
multimodal cognitive intervention for AD patients reported cognitive 
improvement in the word-list recognition and recall tests scores in 
experimental group, but no found statistically significant changes in 
GDS, MMSE and quality of life of patients scores in the experimental 
group before and after treatment5.
Our findings suggest that the multimodal intervention yielded 
improvement in quality of life, as reported by patients with mild AD 
compared to controls. Similar results were also noted in the occupa-
tional therapy program for patients with mild to moderate dementia, 
which showed improved the short term physical performance and 
psychological well-being domain of quality of life, measured by 
the WHOQOL-BREF2. In an earlier study conducted in our group, 
Machado and colleagues35 suggested that psychosocial intervention 
may prove to be an effective strategy to enhance the quality of life of 
AD patients. In the uncontrolled set of data derived from the CIND 
group, we found no statistically significant differences between end-
point and baseline scores on quality of life, in accordance with another 
study made with older adults with mild cognitive impairment30. The 
absence of significant differences in quality of life self-reported by 
CIND patients could be related with a better stability in the social life, 
a different situation that that lived by patients with mild AD. Onor 
and colleagues36 reported that during the rehabilitation program, 
AD patients increased their socialization and created a network of 
alliances and mutual help.
We acknowledge the limitations of the present study. First, the 
relatively small sample size in the mild AD control group. Second, the 
difficulties in forming adequate control group to compare CIND and 
moderate AD. As the focus of our study was older adults with mild 
AD, but during the recruitment phase older adults with moderate 
AD and with CIND were also referred to our service, we decided to 
include these subjects in the rehabilitation program and therefore in 
the study, but analyzing separately their results. In spite of the lack 
of a proper control group (i.e., subjects with a similar condition as-
sessed at baseline and endpoint but not receiving the intervention), 
we believe that this preliminary set of data may help us and other 
researchers in future studies.
In conclusion, our perception is that the multimodal interven-
tion provided was beneficial for patients with mild AD and those 
with CIND. In the moderate AD patients, this intervention did not 
prove beneficial. Future studies with larger samples and rigorous 
randomization methods may be necessary in this area to determine 
the value and cost-benefit ratio of this model of intervention.
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